Viking’s 3DHD visualisation system gets FDA nod
This article was originally published in Clinica
The FDA has granted 510(k) clearance for Viking Systems’ next-generation 3DHD visualisation system. The product is designed for use during minimally-invasive surgery, including urology, gynaecology and spinal procedures. Currently, most of these operations are carried out with a 2D camera, Viking claims. It believes that its device could improve the quality of care, as well as reducing procedure time and therefore costs. The Westborough, Massachusetts firm plans to launch the system at the annual meeting of the American College of Surgeons, to be held on 3-7 October in Washington, DC. Viking is also planning to CE mark the device for sale in Europe by the end of the year.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.